Med Clin 154:171174 Shigiyama F, Kumashiro N, Miyagi M, Ikehara K, Kanda E, Uchino H, Hirose T (2017) Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study
These side effects are usually temporary and improve over time
Interaction between the triglyceride lipase ATGL and the Arf1 activator GBF1
Creates windows where your pituitary must generate its own pulses, training the axis back toward baseline function
The product is not approved for the treatment of any medical condition, including obesity or weight management
Determine whether showing expected progress, better than expected, or disappointing results